Knowledge Tree
Relations (1)
related 6.00 — strongly supporting 6 facts
Ketamine is classified as a 'psychoplastogen' that rapidly enhances neuroplasticity [1], serving as a proposed convergent mechanism for its therapeutic effects {fact:1, fact:6}. This relationship is further supported by clinical models that view the post-treatment 'window of opportunity' as a period of heightened neuroplasticity {fact:3, fact:4}, alongside evidence that ketamine promotes synaptogenesis and neurite growth [2].
Facts (6)
Sources
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org 3 facts
claimKetamine and psilocybin appear to act as 'psychoplastogens,' which are agents that rapidly boost neuroplasticity.
claimKetamine is an off-label treatment that may yield significant but transient psychiatric benefits, potentially by acting through enhanced neuroplasticity.
claimThe Montreal model clinicians utilize the concept of a 'window of opportunity' following ketamine treatment, which refers to a period of symptomatic improvement and potentially enhanced neuroplasticity.
Effects of psychedelics on neurogenesis and broader neuroplasticity link.springer.com 2 facts
claimKetamine exhibits a dual profile regarding neurogenesis and neural plasticity: it promotes synaptogenesis, neurite growth, and new neuron formation in single-dose paradigms, but high doses or neonatal exposure are linked to neurogenesis impairment and long-term cognitive deficits.
referenceAleksandrova and Phillips (2021) identified neuroplasticity as a convergent mechanism shared by ketamine and classical psychedelics.
Neuroimaging in psychedelic drug development: past, present, and ... nature.com 1 fact
claimNeuroplasticity is proposed as a convergent mechanism of action for both ketamine and classical psychedelics.